Taiwan Biomaterial Co., Ltd. Taiwan Biomaterial Co., Ltd.

Taiwan Biomaterial Co., Ltd.

6649

Rank in Stocks #23060
Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan,... Taiwan Biomaterial Co., Ltd., established in 2010 and based in Zhubei, Taiwan, focuses on the innovation, development, and commercialization of medical devices throughout Taiwan. Their product offerings include Foamagen, a pioneering dural substitute characterized by its foamy structure. The company also provides a sophisticated negative pressure catheter system engineered for stroke intervention, which efficiently suctions and removes cerebrovascular embolism blood clots, accompanied by a specialized nickel-titanium guidewire essential for guiding intricate neurovascular procedures. Additionally, Taiwan Biomaterial develops advanced tissue repair and regeneration solutions specifically targeting the treatment of early-stage osteoarthritis.
Share Price
$1.07
Last synced: 2026-11-16
Market Cap
$44.88M
Change (1 day)
-0.69%
Change (1 year)
-29.62%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Taiwan Biomaterial Co., Ltd. (6649)

Category

Healthcare
Dividend history for Taiwan Biomaterial Co., Ltd. (6649)
Taiwan Biomaterial Co., Ltd. (stock symbol: 6649) made a total of 2 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.04
Dividend yield (TTM) : 2.82%
Dividend payments for Taiwan Biomaterial Co., Ltd. (6649) from 2023 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $0.0318 404.03%
2023 $0.0063 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.0318 404.03%
2023 $0.0063 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
176.00%
US
181.00%
IE
87.00%
US
0.00%
US
0.00%
US